- Home
- PTON vs XNCR Comparison
PTON vs XNCR Comparison
Compare PTON & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTON | XNCR |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PTON | XNCR |
|---|---|---|
| Price | $4.92 | $25.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $7.89 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 7.1M | 1.2M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.67 | 65.36 |
| EPS | ★ 0.14 | N/A |
| Revenue | N/A | ★ $125,576,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.44 | $4.80 |
| P/E Ratio | $35.43 | ★ N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $3.65 | $10.24 |
| 52 Week High | $9.20 | $30.61 |
Technical Indicators
Market Signals| Indicator | PTON | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.18 | 51.95 |
| Support Level | $4.44 | $11.05 |
| Resistance Level | $6.00 | $30.61 |
| Average True Range (ATR) | 0.16 | 1.14 |
| MACD | -0.00 | -0.44 |
| Stochastic Oscillator | 12.59 | 27.94 |
Price Performance
Historical ComparisonAbout PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Products derive revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.